帕金森病 (PD) 和非PD患者的REM睡眠特征的夜间分布控制
Andrew Dagay1,2, Shani Oz2,3, Shlomit Katzav4
1Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Journal of Parkinson's disease
|October 9, 2023
概括
快速眼动 (REM) 睡眠行为障碍 (RBD) 是帕金森病的预测因素. 虽然REM密度在一夜之间增加,但在帕金森病患者和对照人群中,REM睡眠没有动 (RSWA%) 均分布,有助于诊断.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 运动障碍 运动障碍
背景情况:
- 快速眼动 (REM) 睡眠行为障碍 (RBD) 是帕金森病 (PD) 的一个重要的早期预测因素.
- 诊断RBD依赖于在睡眠实验室环境中识别病态的REM睡眠没有动 (RSWA).
- 关于RSWA百分比 (RSWA%) 的一夜间分布模式存在相互矛盾的证据.
研究的目的:
- 调查REM密度 (眼动每REM睡眠一分钟) 和RSWA%在患有PD和非PD对照个体的时间分布.
- 为了在PD患者和对照者之间比较这些REM睡眠参数,在不同的睡眠周期和REM周期中进行比较.
主要方法:
- 一组51名参与者 (28名患有PD,23名对照) 接受了过夜的多睡眠图.
- 在四个夜间睡眠周期中量化和分析了REM密度和RSWA%.
- 单独进行临床评估,以评估PD状态.
主要成果:
- 与对照组相比,患有PD的参与者表现出较低的REM密度和更高的RSWA%.
- 雷姆睡眠密度在早晨时段呈现上升趋势.
- 在PD患者和对照组中,RSWA%的分布在整个晚上都是一致的.
结论:
- 帕金森病病理学会影响特定的REM睡眠特征,但不会改变它们在夜间的分布.
- RSWA%在整个晚上均分布,这表明任何睡眠周期都适合其评估.
- 减少REM密度可以作为PD的潜在生物标志物,而一致的RSWA%分布有助于RBD诊断.
相关概念视频
REM Sleep Behavior Disorder
217
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
217
Parkinson's Disease: Treatment
287
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
287
Stages of Sleep
219
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
219
Sleep-Wake Cycles
1.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
Narcolepsy
122
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
122
Parkinson's Disease: Overview
587
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
587


